...
首页> 外文期刊>Nanotechnology >Papain grafted into the silica coated iron-based magnetic nanoparticles 'IONPs@SiO2-PPN' as a new delivery vehicle to the HeLa cells
【24h】

Papain grafted into the silica coated iron-based magnetic nanoparticles 'IONPs@SiO2-PPN' as a new delivery vehicle to the HeLa cells

机译:纸木涂层进入二氧化硅涂层的铁基磁性纳米颗粒'IONPS @ SiO2-PPN'作为Hela细胞的新送货车

获取原文
获取原文并翻译 | 示例
           

摘要

The present study aims at engineering, fabrication, characterization, and qualifications of papain (PPN) conjugated SiO2-coated iron oxide nanoparticles 'IONPs@SiO2-PPN'. Initially fabricated iron oxide nanoparticles (IONPs) were coated with silica (SiO2) using sol-gel method to hinder the aggregation and to enhance biocompatibility. Next, PPN was loaded as an anticancer agent into the silica coated IONPs (IONPs@SiO2) for the delivery of papain to the HeLa cancer cells. This fabricated silica-coated based magnetic nanoparticle is introduced as a new physiologically-compatible and stable drug delivery vehicle for delivering of PPN to the HeLa cancer cell line. The IONPs@SiO2-PPN were characterized using FT-IR, AAS, FESEM, XRD, DLS, and VSM equipment. Silica was amended on the surface of iron oxide nanoparticles (IONPs, gamma-Fe2O3) to modify its biocompatibility and stability. The solvent evaporation method was used to activate PPN vectorization. The following tests were performed to highlight the compatibility of our proposed delivery vehicle: in vitro toxicity assay, in vivo acute systemic toxicity test, and the histology examination. The results demonstrated that IONPs@SiO2-PPN successfully reduced the IC50 values compared with the native PPN. Also, the structural alternations of HeLa cells exposed to IONPs@SiO2-PPN exhibited higher typical hallmarks of apoptosis compared to the cells treated with the native PPN. The in vivo acute toxicity test indicated no clinical signs of distress/discomfort or weight loss in Balb/C mice a week after the intravenous injection of IONPs@SiO2 (10 mg kg(-1)). Besides, the tissues architectures were not affected and the pathological inflammatory alternations detection failed. In conclusion, IONPs@SiO2-PPN can be chosen as a potent candidate for further medical applications in the future, for instance as a drug delivery vehicle or hyperthermia agent.
机译:目前的研究旨在占地面积(PPN)缀合的SiO2涂层氧化铁纳米粒子'SiO2-PPN'的工程,制造,表征和资格。使用溶胶 - 凝胶法涂覆初始制造的氧化铁纳米颗粒(IOO2)涂覆二氧化硅(SiO 2),以阻止聚集并增强生物相容性。接下来,将PPN作为抗癌剂加载到二氧化硅涂覆的IONPS(IONPS @ SiO 2)中以将毒素递送到HELA癌细胞。将该制造的二氧化硅涂覆的磁性纳米颗粒作为新的生理学兼容且稳定的药物递送载体,用于递送PPN至HeLa癌细胞系。使用FT-IR,AAS,FESEM,XRD,DLS和VSM设备表征IONPS @ SiO2-PPN。在氧化铁纳米颗粒(IONPS,Gamma-Fe2O3)的表面上修正二氧化硅以改变其生物相容性和稳定性。使用溶剂蒸发方法激活PPN升降。进行了以下测试以突出我们所提出的递送车辆的兼容性:体外毒性测定,体内急性全身毒性试验以及组织学检查。结果表明,与天然PPN相比,IONPS @ SiO2-PPN成功地降低了IC50值。此外,与用天然PPN处理的细胞相比,暴露于IONPS的HERA细胞的结构交替表现出更高的凋亡标志性凋亡。体内急性毒性试验表明,在静脉注射IOIO2(10mg kg(-1))后,每周在Balb / c小鼠中没有患有痛苦/不适或体重减轻的临床迹象。此外,组织架构不受影响,病理炎症替换检测失败。总之,IONPS @ SiO2-PPN可以选择作为未来进一步医疗应用的有效候选者,例如作为药物递送载体或热疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号